PRP for diabetic retinopathy

Ranibizumab Found Effective Against Diabetic Retinopathy

In a randomized clinical trial conducted by of more than 300 participants, researchers have found that ranibizumab is an effective alternative to Panretinal photocoagulation (PRP) (laser therapy for treating diabetic retinopathy). Results also show that the drug therapy carries fewer side effects than the currently used laser treatment.

Dr Allen Ho

Less than Half of US Adults Understand Their Risk for Vision Loss from Diabetes

A new survey at the start of Diabetes Awareness Month (by Regeneron Pharmaceuticals Inc.) has found that less than half of recently surveyed U.S. adults with diabetes recognize their risk for vision loss. The survey also found that less than one-fifth (18%) of respondents were familiar with diabetic macular edema (DME). The survey found that nearly one


Patients waiting for an eye exam

Visit to Cochabamba, Bolivia

This visit was supported by a grant from Alcon Foundation. As part of our outreach into South America, we visited Cochabamba in Bolivia the week of Oct 26, 2015. We are collaborating with the Fundación Boliviana de Oftalmología to help develop retinal services in the country. Dr Oscar Cortex and his son, Dr Rodrigo Cortes, manage this


Hydroxychloroquine toxicity

Hydroxychloroquine screening lacks adherence to recommended guidelines

Of patients presenting for hydroxychloroquine screening at a large multispecialty ophthalmic practice, almost half of the patients on hydroxychoroquine did not receive appropriate evaluation, indicating lack of adherence to guidelines. Spectral-domain optical coherence tomography (SD OCT) and 10-2 Humphrey visual field (HVF) were found to be the preferred screening modalities, with others being fundus autofluorescence (FAF)


Ocular gene therapy

Gene therapy for neovascular age-related macular degeneration safe at 1 year

Results from a single-center, phase 1, randomized controlled clinical trial show that ocular gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration was found to be safe and well tolerated. The study enrolled patients with wet age-related macular degeneration at the Lions Eye Institute and the Sir Charles Gairdner Hospital in Nedlands, WA, Australia. Eligible